Mark E. Robson Discusses When Genetic Testing Is Needed

Video

​Mark E. Robson, MD, Clinical Director of the Clinical Genetics Services at Memorial Sloan Kettering Cancer Center, discusses when it is appropriate to go for genetic testing to determine cancer risk.

Mark E. Robson, MD, Clinical Director of the Clinical Genetics Services at Memorial Sloan Kettering Cancer Center, discusses when it is appropriate to go for genetic testing to determine cancer risk.

Robson says that the criteria for genetic testing is becoming broader, and more people are familiar with the process and costs of testing have decreased. However, he notes that not everyone should be tested for every type of malignancy. Genetic testing is most appropriate for people with family history of certain cancers or who experienced certain cancers, such as triple-negative breast cancer or colon cancer, at a young age.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.